Patrick James Orme

Array ( [id] => 4705127 [patent_doc_number] => 20080064651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'TRPM-2 Antisense Therapy' [patent_app_type] => utility [patent_app_number] => 11/875226 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 4870 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064651.pdf [firstpage_image] =>[orig_patent_app_number] => 11875226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6517001 [patent_doc_number] => 20100216864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'RNA Antagonist Compounds for the Modulation of PCSK9' [patent_app_type] => utility [patent_app_number] => 12/444806 [patent_app_country] => US [patent_app_date] => 2007-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25282 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216864.pdf [firstpage_image] =>[orig_patent_app_number] => 12444806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4944048 [patent_doc_number] => 20080081373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-03 [patent_title] => 'Genetic inhibition by double-stranded RNA' [patent_app_type] => utility [patent_app_number] => 11/905449 [patent_app_country] => US [patent_app_date] => 2007-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14026 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20080081373.pdf [firstpage_image] =>[orig_patent_app_number] => 11905449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321798 [patent_doc_number] => 20100113558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'COMPOUNDS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/444043 [patent_app_country] => US [patent_app_date] => 2007-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4895 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113558.pdf [firstpage_image] =>[orig_patent_app_number] => 12444043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682350 [patent_doc_number] => 20080248576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Genetic Inhibition of double-stranded RNA' [patent_app_type] => utility [patent_app_number] => 11/905368 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14021 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248576.pdf [firstpage_image] =>[orig_patent_app_number] => 11905368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879779 [patent_doc_number] => 20080153162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'DOUBLE-STRANDED AND SINGLE-STRANDED RNA MOLECULES WITH 5\' TRIPHOSPHATES AND THEIR USE FOR INDUCING INTERFERON' [patent_app_type] => utility [patent_app_number] => 11/859306 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 15069 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153162.pdf [firstpage_image] =>[orig_patent_app_number] => 11859306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6447271 [patent_doc_number] => 20100144830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'CANCER CELL IDENTIFICATION MARKER AND CANCER CELL PROLIFERATION INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/441747 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15527 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144830.pdf [firstpage_image] =>[orig_patent_app_number] => 12441747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574855 [patent_doc_number] => 07825101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Modulation of MLCK-L expression and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/439370 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12826 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/825/07825101.pdf [firstpage_image] =>[orig_patent_app_number] => 12439370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9995894 [patent_doc_number] => 09040491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => 'Compositions, methods and kits based on small nuclear RNAs' [patent_app_type] => utility [patent_app_number] => 11/897052 [patent_app_country] => US [patent_app_date] => 2007-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 42 [patent_no_of_words] => 24004 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11897052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616820 [patent_doc_number] => 20100099737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING MYELOSUPPRESSION' [patent_app_type] => utility [patent_app_number] => 12/438471 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12629 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099737.pdf [firstpage_image] =>[orig_patent_app_number] => 12438471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4585162 [patent_doc_number] => 07851615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Lipophilic conjugated iRNA agents' [patent_app_type] => utility [patent_app_number] => 11/833934 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 20504 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851615.pdf [firstpage_image] =>[orig_patent_app_number] => 11833934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728339 [patent_doc_number] => 20080207883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes' [patent_app_type] => utility [patent_app_number] => 11/832411 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 28464 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207883.pdf [firstpage_image] =>[orig_patent_app_number] => 11832411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4699133 [patent_doc_number] => 20080221317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'siRNA targeting cystic fibrosis transmembrane conductance regulator (CFTR)' [patent_app_type] => utility [patent_app_number] => 11/881386 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 35197 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221317.pdf [firstpage_image] =>[orig_patent_app_number] => 11881386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728340 [patent_doc_number] => 20080207884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'siRNA targeting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC)' [patent_app_type] => utility [patent_app_number] => 11/880776 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 34726 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207884.pdf [firstpage_image] =>[orig_patent_app_number] => 11880776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375770 [patent_doc_number] => 20100076054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'SENSIZITATION OF CANCER CELLS TO THERAPY USING SINA TARGETING GENES FROM THE 1P AND 19Q CHROMOSOMAL REGIONS' [patent_app_type] => utility [patent_app_number] => 12/375960 [patent_app_country] => US [patent_app_date] => 2007-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8036 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076054.pdf [firstpage_image] =>[orig_patent_app_number] => 12375960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509084 [patent_doc_number] => 20090082291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Methods of treatment of acute renal failure' [patent_app_type] => utility [patent_app_number] => 11/827199 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14090 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082291.pdf [firstpage_image] =>[orig_patent_app_number] => 11827199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189721 [patent_doc_number] => 20110172120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Compositions and Systems for the Regulation of Genes' [patent_app_type] => utility [patent_app_number] => 11/774177 [patent_app_country] => US [patent_app_date] => 2007-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 32232 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172120.pdf [firstpage_image] =>[orig_patent_app_number] => 11774177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600363 [patent_doc_number] => 20100292299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Nucleotide Motifs Providing Localization Elements and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/308811 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19020 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292299.pdf [firstpage_image] =>[orig_patent_app_number] => 12308811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527970 [patent_doc_number] => 20090198047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => '2\'-Modified Oligonucleotides' [patent_app_type] => utility [patent_app_number] => 11/764087 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31582 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20090198047.pdf [firstpage_image] =>[orig_patent_app_number] => 11764087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4688764 [patent_doc_number] => 20080032945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => '2\'-MODIFIED OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 11/764086 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31522 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20080032945.pdf [firstpage_image] =>[orig_patent_app_number] => 11764086 [rel_patent_id] =>[rel_patent_doc_number] =>)